XCancer

Study on the Safety and Effectiveness of NRT6003 Injection in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Description:

The goal of this clinical trial is to evaluate the safety and efficacy of NRT6003 Injection in patients with unresectable HCC.

Sponsor:

Chengdu New Radiomedicine

Phase:

Phase 1

Government Study Link:

NCT06310590 - Click here to see study on

ClinicalTrials.gov